Error: Could not add to watchlist. X

KaloBios Pharmaceuticals Inc

+ Watchlist
KBIO:US
NASDAQ GM
0.490
USD
0.009
1.80%
As of 20:10:00 ET on 07/03/2015.
Open
0.499
Day Range
0.462 - 0.510
Volume
177,682
Previous Close
0.499
52Wk Range
0.362 - 2.340
1 Yr Return
-78.97%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.098
Market Cap (m USD)
16.168
Shares Outstanding (m)
32.995
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
KaloBios Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops monoclonal antibodies designed to improve the lives of seriously ill patients with difficult-to-treat diseases, focusing on respiratory diseases and cancer such as cystic fibrosis, asthma, pneumonia, and tumors. KaloBios serves patients throughout the United States.
ADDRESS
442 Littlefield Avenue
South San Francisco, CA 94080
United States
PHONE
1-650-243-3100
  • Ronald A Martell
    Chairman
  • Herbert C Cross "Herb"
    Interim CEO/CFO
  • Donald R Joseph "Don"
    Chief Legal Officer
  • Geoffrey T Yarranton
    Chief Scientific Officer
Show More